HIGHLIGHTS
- who: Dehai Wang from the Department of General Surgery, The Second Hospital, Cheeloo College of Medicine, Shandong University, Shandong Province, People's Republic of China have published the research work: DUB1 suppresses Hippo signaling by modulating TAZ protein expression in gastric cancer, in the Journal: (JOURNAL)
- what: The authors propose that inhibition of DUB1 expression or pharmaceutical targeting of DUB1 function could be a promising strategy to suppress Hippo/TAZ-driven gastric cancers. Considering these results collectively with the conclusion that DUB1 stabilizes TAZ in cancer progression, the authors propose that targeting DUB1 could block . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.